1. Home
  2. TANH vs ACXP Comparison

TANH vs ACXP Comparison

Compare TANH & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tantech Holdings Ltd.

TANH

Tantech Holdings Ltd.

HOLD

Current Price

$1.00

Market Cap

6.2M

Sector

N/A

ML Signal

HOLD

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$2.72

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TANH
ACXP
Founded
2001
2017
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
6.8M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
TANH
ACXP
Price
$1.00
$2.72
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$143.67
AVG Volume (30 Days)
49.7K
57.8K
Earning Date
05-15-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.88
N/A
Revenue
$41,982,988.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$2.44
52 Week High
$6.98
$21.00

Technical Indicators

Market Signals
Indicator
TANH
ACXP
Relative Strength Index (RSI) 44.56 35.73
Support Level $0.98 $2.65
Resistance Level $1.05 $3.07
Average True Range (ATR) 0.07 0.23
MACD 0.01 0.03
Stochastic Oscillator 62.46 27.27

Price Performance

Historical Comparison
TANH
ACXP

About TANH Tantech Holdings Ltd.

Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company, through its subsidiaries, is engaged in the production and distribution of household products along with a trading business, which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments: the Consumer Product segment, and the Electric Vehicle (EV) segment.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

Share on Social Networks: